This pilot study investigated effectiveness and tolerability of
risperidone for the treatment of psychosis and agitation in 9 inpatients
with Parkinson's disease and dementia. Investigators found risperidone to
be effective and safe, without worsening extrapyramidal symptoms or further
impairing cognition.
Abstract Teaser